Novo Nordisk has agreed to buy Akero Therapeutics and its drug candidate for metabolic dysfunction-associated steatohepatitis (MASH) for $4.7 billion upfront, shortly after claiming FDA approval to ...

After a containment breach unleashes Catnap into the Playtime Co. factory, Player is attacked! The vicious Catnap is trying to protect his Smiling Critter friends from the evil CEO. Dogday, Bubba ...

We might earn a commission if you make a purchase through one of the links. The McClatchy Commerce Content team, which is independent from our newsroom, oversees this content. This article has ...